Regulatory

CLINUVEL
Posted by CLINUVEL
September 23, 2022
CLINUVEL
Posted by CLINUVEL
September 8, 2022

CLINUVEL confirms AGM date

CLINUVEL confirms the date for the Company’s 2022 Annual General Meeting.

Read More
Lachlan Hay
Posted by Lachlan Hay
September 5, 2022

CLINUVEL submits SCENESSE® label expansion for adolescent EPP patients

European regulatory submission follows clinical support for SCENESSE® treatment in EPP patients...

Read More
CLINUVEL
Posted by CLINUVEL
August 31, 2022

CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2022

CLINUVEL PHARMACEUTICALS LTD hosted an investor webinar on the financial results for...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Appendix 4G

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4G

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Revenue Growth Drives CLINUVEL's Sixth Consecutive Annual Profit

CLINUVEL today announced its sixth consecutive annual net profit, driven by revenues...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Dividend/Distribution – CUV

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4E and Annual Report

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2022

Appendix 4E & Annual Report

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4E and Annual Report

Read More
CLINUVEL
Posted by CLINUVEL
July 25, 2022

Appendix 4C & Activity Report

CLINUVEL PHARMACEUTICALS LTD today released its Appendix 4C – Quarterly Cashflow Report...

Read More
CLINUVEL
Posted by CLINUVEL
June 23, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 23 June 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 14, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 14 June 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 14, 2022

Notice of ceasing to be a substantial holder

Melbourne, Australia, 14 June 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
May 25, 2022

Notice of change of interests of initial substantial holder

Melbourne, Australia, 25 May 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
May 20, 2022

Notice of initial substantial holder

Melbourne, Australia, 20 May 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
May 12, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 12 May 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More